NCT06634121 Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population
| NCT ID | NCT06634121 |
| Status | Recruiting |
| Phase | — |
| Sponsor | LMU Klinikum |
| Condition | Mitral Regurgitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2024-04-01 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate potential differences in procedural outcomes of both commercially available transcatheter edge-to-edge mitral valve repair devices in a non-selected clinical setting.
Eligibility Criteria
Inclusion Criteria: * Age equal or above 18 years * Written consent * Heart Team recommends M-TEER Exclusion Criteria: * Mitral Stenosis (MV mean PG \> 5 mmHg) * Cardiogenic shock or hemodynamic instability at the time of intervention * Active endocarditis * Participant in another interventional cardiology study
Contact & Investigator
Jörg Hausleiter, Prof. Dr.
PRINCIPAL INVESTIGATOR
LMU Klinikum
Frequently Asked Questions
Who can join the NCT06634121 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mitral Regurgitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06634121 currently recruiting?
Yes, NCT06634121 is actively recruiting participants. Contact the research team at Joerg.Hausleiter@med.uni-muenchen.de for enrollment information.
Where is the NCT06634121 trial being conducted?
This trial is being conducted at Munich, Germany.
Who is sponsoring the NCT06634121 clinical trial?
NCT06634121 is sponsored by LMU Klinikum. The principal investigator is Jörg Hausleiter, Prof. Dr. at LMU Klinikum. The trial plans to enroll 180 participants.